Ongoing Developments in Biologic Therapy


Registration benefits include:
Access to CME/CE programs and certification
Free subscription to Biologic Bulletin newsletter
Reminders of new CME/CE activities
REGISTER NOW

Ask the Expert : Ask the Expert Question
Ask the Expert
Biologic treatment in patients with successfully treated skin cancer
Linda Stein Gold, MD
May 6, 2008

Question:
I recently had a squamous cell carcinoma that was caused by too many PUVA treatments removed. Is there a biologic that would be safe for my very severe psoriasis, even though I have had skin cancer? I have been told that I have to wait at least 5 years until I can use any biologic.

Answer:
A history of basal cell carcinoma or nonmetastatic successfully treated squamous cell carcinoma is usually allowed for our biologics studies, including efalizumab and IL-12/23 agents. Studies with adalimumab did exclude skin cancers. The prescribing information for etanercept states no specific contraindication for patients with skin cancer.

I am comfortable treating patients with successfully treated skin cancer with biologic agents. It has been recommended that patients wait a minimum of 5 years before biologic therapy if they have a history of noncutaneous skin cancer. I usually do not use biologic agents in patients with any history of noncutaneous skin cancer.

  Ask the Expert Home